KDU691 - PI4K 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
KDU691 - PI4K 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
KDU691 - PI4K 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEKDU691Cat. No.: HY-12912CAS No.: 1513879-19-0分式: CHClNO分量: 419.86作靶点: PI4K作通路: PI3K/Akt/mTOR储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 150 mg/mL (357.26 mM; Need ultrasonic and warming

2、)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.3817 mL 11.9087 mL 23.8175 mL5 mM 0.4763 mL 2.3817 mL 4.7635 mL10 mM 0.2382 mL 1.1909 mL 2.3817 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶

3、剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (5.95 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (5.95 mM); Clear solution3. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (5.95 mM); Clear sol

4、ution1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEBIOLOGICAL ACTIVITY物活性 KDU691个 PI4K 抑制剂。IC50 & Target PI4K体内研究 During the 5 days of dosing, no major weight changes are observed in the animals that receive KDU691 asprophylactic treatment (group 691-proph). From the fourth day of dosing, the ani

5、mals that are treated withKDU691 show a transient yellow skin color. The KDU691 radical-cure group (group 691-RC) becomes blood-stage positive again at 31.80.5 days p.i. (range, 31 to 32 days). Clinical chemistry analysis of the group 691-RC monkeys reveals that bilirubin levels accumulate during th

6、e 5-day radical-cure treatment with KDU6911.PROTOCOLAnimal For in vivo PK studies, female CD-1 mice (25 to 30g) are used and randomly assigned to cages. Mice areAdministration 1 allowed to acclimate before initiation of the experiments. Feed and water are given ad libitum. KDU691 isformulated at con

7、centrations of 2.5 mg/mL and 0.25 mg/mL for a dose of 25 mg/kg and 2.5 mg/kg,respectively. The suspension formulation for p.o. dosing contains 0.5% Methyl cellulose and 0.5% Tween 80in water. After oral dosing, blood and liver samples from mice are collected at 0.08 to 24 h post dosing.Groups of thr

8、ee mice are used for each time point. Blood is centrifuged at 13,000 rpm for 7 min at 4C,plasma harvested and stored at -20C until analysis. Liver tissue samples are excised, dipped in PBS, gentlyblotted with absorbent paper, dried, weighed and stored at -20C until further analysis 1.MCE has not ind

9、ependently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Zeeman AM, et al. PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.Antimicrob Agents Chemother. 2016 Apr 22;60(5):2858-63.McePdfHeightCaution: Product has not been fully validated for medica

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论